Loading...
399

Starcoin Group LimitedSEHK:399 Stock Report

Market Cap HK$467.1m
Share Price
HK$0.22
My Fair Value
n/a
1Y9.9%
7D-9.8%
Portfolio Value
View

Starcoin Group Limited

SEHK:399 Stock Report

Market Cap: HK$467.1m

Starcoin Group (399) Stock Overview

An investment holding company, engages in the trading of beauty products in the People’s Republic of China and Hong Kong. More details

399 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

399 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

US$9.21
2.8% undervalued intrinsic discount
Revenue growth
64.98% p.a.
Profit Margin
15%
Future PE
35x
Share price in 2030
US$14.83

Starcoin Group Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Starcoin Group
Historical stock prices
Current Share PriceHK$0.22
52 Week HighHK$0.73
52 Week LowHK$0.14
Beta-0.73
1 Month Change-38.33%
3 Month Change-58.89%
1 Year Change9.90%
3 Year Change20.00%
5 Year Change-11.20%
Change since IPO-99.81%

Recent News & Updates

Recent updates

We Believe That Innovative Pharmaceutical Biotech's (HKG:399) Weak Earnings Are A Good Indicator Of Underlying Profitability

Jan 03
We Believe That Innovative Pharmaceutical Biotech's (HKG:399) Weak Earnings Are A Good Indicator Of Underlying Profitability

Innovative Pharmaceutical Biotech (HKG:399) Has Debt But No Earnings; Should You Worry?

Aug 12
Innovative Pharmaceutical Biotech (HKG:399) Has Debt But No Earnings; Should You Worry?

Robust Earnings May Not Tell The Whole Story For Innovative Pharmaceutical Biotech (HKG:399)

Jan 05
Robust Earnings May Not Tell The Whole Story For Innovative Pharmaceutical Biotech (HKG:399)

Is Innovative Pharmaceutical Biotech (HKG:399) Using Too Much Debt?

Feb 18
Is Innovative Pharmaceutical Biotech (HKG:399) Using Too Much Debt?

Innovative Pharmaceutical Biotech's(HKG:399) Share Price Is Down 80% Over The Past Five Years.

Nov 26
Innovative Pharmaceutical Biotech's(HKG:399) Share Price Is Down 80% Over The Past Five Years.

Shareholder Returns

399HK Trade DistributorsHK Market
7D-9.8%-1.2%-0.9%
1Y9.9%1.1%29.8%

Return vs Industry: 399 exceeded the Hong Kong Trade Distributors industry which returned 1.1% over the past year.

Return vs Market: 399 underperformed the Hong Kong Market which returned 29.8% over the past year.

Price Volatility

Is 399's price volatile compared to industry and market?
399 volatility
399 Average Weekly Movement13.2%
Trade Distributors Industry Average Movement9.5%
Market Average Movement7.1%
10% most volatile stocks in HK Market14.9%
10% least volatile stocks in HK Market3.3%

Stable Share Price: 399's share price has been volatile over the past 3 months compared to the Hong Kong market.

Volatility Over Time: 399's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
200020Ming Wuwww.starcoingroup.com

Starcoin Group Limited, an investment holding company, engages in the trading of beauty products in the People’s Republic of China and Hong Kong. It operates in two segments, Trading of Beauty Products, and Research and Development. The company is also involved in the research, development, and commercialization of oral insulin products; and the provision of genetic testing services, as well as securities investment.

Starcoin Group Limited Fundamentals Summary

How do Starcoin Group's earnings and revenue compare to its market cap?
399 fundamental statistics
Market capHK$467.13m
Earnings (TTM)-HK$345.94m
Revenue (TTM)HK$2.09m
227.5x
P/S Ratio
-1.4x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
399 income statement (TTM)
RevenueHK$2.09m
Cost of RevenueHK$1.90m
Gross ProfitHK$188.00k
Other ExpensesHK$346.13m
Earnings-HK$345.94m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.16
Gross Margin8.99%
Net Profit Margin-16,544.09%
Debt/Equity Ratio4,140.5%

How did 399 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/06 11:02
End of Day Share Price 2025/11/06 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Starcoin Group Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.